These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6149536)

  • 1. [Originality of the mode of action of almitrine dimesylate].
    Tellier P
    Presse Med; 1984 Oct; 13(34):2083-9. PubMed ID: 6149536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Almitrine dimesylate: deductions and therapeutic prospects].
    Tellier P; Voisin C
    Presse Med; 1984 Oct; 13(34):2099-103. PubMed ID: 6149539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Almitrine bismesylate and ventilation-perfusion ratios].
    Evrard Y
    Rev Mal Respir; 1985; 2 Suppl 1():S17-22. PubMed ID: 2870542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological properties of almitrine dimesylate. Effects on the ventilation-perfusion ratio].
    Evrard Y
    Presse Med; 1984 Oct; 13(34):2063-9. PubMed ID: 6149533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo].
    Paramelle B; Joubert C; Dain MP
    Presse Med; 1984 Oct; 13(34):2094-8. PubMed ID: 6149538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The almitrine dimesylate molecule. Various structure-activity relationship aspects].
    Labrid C; Regnier G
    Presse Med; 1984 Oct; 13(34):2059-62. PubMed ID: 6149532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
    Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E
    Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of almitrine bismesylate 100 mg daily for four weeks on respiratory regulation in patients with chronic bronchitis.
    Stanley NN
    Eur J Respir Dis Suppl; 1986; 146():635-9. PubMed ID: 3096763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Almitrine bismesylate.
    Tweney J; Howard P
    Z Erkr Atmungsorgane; 1987; 168(3):197-215. PubMed ID: 2890242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Should arterial gas values be improved in patients with chronic bronchitic respiratory insufficiency? Value of almitrine dimesylate].
    Prefaut C
    Presse Med; 1984 Oct; 13(34):2090-3. PubMed ID: 6149537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
    Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
    Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
    Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
    Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of almitrine and oxygen on ventilation and gas exchange in patients with chronic respiratory insufficiency.
    Hawryłkiewicz I; Jedrzejewska-Makowska M; Górecka D; Zieliński J
    Eur J Respir Dis; 1983 Oct; 64(7):512-6. PubMed ID: 6138276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology].
    Mihalţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):209-19. PubMed ID: 2894713
    [No Abstract]   [Full Text] [Related]  

  • 16. [Future prospects concerning the clinical application and clinical pharmacology of almitrine dimesylate].
    Duroux P
    Rev Med Interne; 1985; 6 Spec No():59-60. PubMed ID: 3834560
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological properties of almitrine bismesylate.
    Lockhart A
    Eur J Respir Dis Suppl; 1983; 126():225-31. PubMed ID: 6586437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in ventilation-perfusion matching by almitrine in COPD.
    Mélot C; Naeije R; Rothschild T; Mertens P; Mols P; Hallemans R
    Chest; 1983 Mar; 83(3):528-33. PubMed ID: 6130897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Almitrine enhances in low dose the reactivity of pulmonary vessels to hypoxia.
    Nakanishi S; Hiramoto T; Ahmed N; Nishimoto Y
    Respir Physiol; 1988 Nov; 74(2):139-50. PubMed ID: 2906450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dyspnea in chronic bronchitis patients. A method for diagnosis and monitoring therapeutic efficacy].
    Tellier P
    Presse Med; 1984 Oct; 13(34):2049-53. PubMed ID: 6149531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.